Endothelium-dependent relaxation of isolated splanchnic arteries from cirrhotic patients: Role of reactive oxygen species

Hepatology Research

Volumn 37, Issue 10, 2007, Pages 811-819

  Salcedo, Adely ^a   Garijo, Jesús ^a   Monge, Luis ^a   Sánchez, Ana ^a   Fernández, Nuria ^a   García Villalón, Angel L ^a   Turrión, Víctor S ^a   Cuervas Mons, Valentín ^a   Diéguez, Godofredo ^a  

^a AUTONOMOUS UNIVERSITY OF MADRID   (Spain)

Author keywords

Endothelium derived hyperpolarizing factor; Hepatic arteries; Nitric oxide; Potassium Ca channels; Prostacyclin

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ACETYLCHOLINE; CARBAMIC ACID DERIVATIVE; CATALASE; CHARYBDOTOXIN; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; MECLOFENAMIC ACID; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PROSTACYCLIN; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TIRON;

ADULT; AGED; ARTERY CONSTRICTION; ARTERY ENDOTHELIUM; ARTICLE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; HEPATIC ARTERY; HUMAN; HUMAN TISSUE; LIVER CIRRHOSIS; MALE; MESENTERIC ARTERY; PRIORITY JOURNAL; SPLANCHNIC BLOOD FLOW; TENSION; VASODILATATION;

EID: 34548165333     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2007.00135.x     Document Type: Article

References (18)

1. Hadoke PVF, Hayes PC. In vitro evidence for vascular hyporesponsiveness in clinical and experimental cirrhosis. Pharmacol Ther 1997; 75: 51-68.
2. Wiest R, Groszmann RJ. The paradox of nitric oxide in cirrhosis and portal hypertension: Too much, not enough. Hepatology 2002; 35: 478-91.
3. Albillos A, Rossi I, Cacho G et al. 1995. Enhanced endothelium-dependent vasodilation in patients with cirrhosis. Am J Physiol 1995; 268: G459-64.
4. Claria J, Jiménez W, Ros J et al. Increased nitric oxide-dependent vasorelaxation in aortic rings of cirrhotic rats with ascites. Hepatology 1994; 20: 1615-21.
5. Colle IO, De Vriese AS, Van Vlierberghe HR, Lameire NH, De Vos MM. Vascular hyporesponsiveness in the mesenteric artery of anaesthetized rats with cirrhosis and portal hypertension: An in-vivo study. Eur J Gastroenterol Hepatol 2004; 16: 139-45.
6. Mathie RT, Ralevic V, Moore KP, Burnstock G. Mesenteric vasodilator responses in cirrhotic rats: A role for nitric oxide? Hepatology 1996; 23: 130-6.
7. Szuster-Ciesielska A, Daniluk J, Kandefer-Szerse NM. Oxidative stress in the blood of patients with alcohol-related liver cirrhosis. Med Sci Monit 2002; 8: CR419-24.
8. Adachi T, Togashi HA, Suzuki A et al. NAD (P) H oxidase plays a crucial role in PDGF-induced proliferation of hepatic stellate cells. Hepatology 2005; 41: 1272-81.
9. Ljubuncic P, Tanne Z, Bomzon A. Evidence of a systemic phenomenon for oxidative stress in cholestatic liver disease. Gut 2000; 47: 710-16.
10. Bomzon A, Ljubuncic P. Oxidative stress and vascular smooth muscle cell function in liver disease. Pharmacol Ther 2001; 89: 295-308.
11. Fernando B, Marley R, Holt S et al. N-acetylcysteine prevents development of the hyperdynamic circulation in the portal hypertensive rat. Hepatology 1998; 28: 689-94.
12. Huang YT, Hsu YC, Chen CJ, Liu CT, Wei YH. Oxidative-stress-related changes in the livers of bile-duct-ligated rat. J Biomed Sci 2003; 10: 170-8.
13. Zygmunt PM, Ryman T, Hogestatt ED. Regional differences in endothelium-dependent relaxation in the rat: Contribution of nitric oxide and nitric oxide independent mechanisms. Acta Physiol Scand 1995; 155: 257-66.
14. Chauha S, Rahman A, Nilsson H, Clapp L, MacAllister R, Ahluwalia A. NO contributes to EDRF-like response in rat small arteries: A role for NO stores. Cardiovasc Res 2003; 57: 207-16.
15. Barriere E, Tazi KA, Rona J-P et al. Evidence for an endothelium-derived hyperpolarizing factor in the superior mesenteric artery from rats with cirrhosis. Hepatology 2000; 32: 935-41.
16. Hou MC, Cahil PA, Zhan S et al. Enhanced cyclooxygenase-1 expression within the superior mesenteric artery of portal hypertensive rats: Role in the hyperdynamic circulation. Hepatology 1998; 2: 20-7.
17. Kojda G, Harrison D. Interactions between NO and reactive oxygen species; pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure. Cardiovasc Res 1999; 43: 562-71.
18. Griendling KK, FitzGerald GA. Oxidative stress and cardiovascular injury. Part I. Basic mechanisms and in vivo monitoring of ROS. Circulation 2003; 108: 1912-16.